Both in Pharmaceuticals
ARS Pharmaceuticals vs Canopy Growth
Over the past year SPRY returned −65.0% and CGC returned −33.5%; their daily moves had a correlation of 0.09.
SPRY −65.0% CGC −33.5%Growth of $1, one year, split-adjusted
| Metric | SPRY | CGC |
|---|---|---|
| Price | $3.05 | $0.7517 |
| Market cap | $303.3M | $318.0M |
| Today | 0.00% | +6.37% |
| 1 month | −29.0% | −15.6% |
| 6 months | −67.1% | −34.6% |
| Year to date | −73.8% | −34.1% |
| 1 year | −64.6% | −37.4% |
| Revenue growth (YoY) | +114.2% | +7.8% |
| Gross margin | 61.8% | 27.4% |
| Net margin | −185.2% | −18.0% |
| P/E (TTM) | — | — |
| Price / sales | 2.6× | 1.3× |
| Net cash | -$27.8M | $67.9M |
| Dividend yield | — | — |
| Volatility (60d) | 69.9% | 42.5% |
| Short % of float | 40.5% | 7.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).